Literature DB >> 8644738

Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype.

J Gudmundsson1, G Johannesdottir, A Arason, J T Bergthorsson, S Ingvarsson, V Egilsson, R B Barkardottir.   

Abstract

Cloning of a breast cancer-predisposing gene (BRCA2) on chromosome 13Q12-14 has been reported recently. We analyzed seven large Icelandic breast cancer families with markers from the BRCA2 region. Five families showed strong evidence of linkage. The maximum two-point LOD scores for the five BRCA2-linked families ranged from 1.06 to 3.19. Haplotype analyses revealed a region with identical allele sizes between the families, suggesting that they have inherited the mutation from a common ancestor. Cancer types other than breast cancer occur in individuals, segregating the affected haplotype within these families. This suggests that mutations in the gene may also confer some risk of other malignancies in both males and females.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8644738      PMCID: PMC1914693     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  20 in total

1.  Segregation and linkage analysis of nine Utah breast cancer pedigrees.

Authors:  D T Bishop; L Cannon-Albright; T McLellan; E J Gardner; M H Skolnick
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

2.  Familial breast-ovarian cancer locus on chromosome 17q12-q23.

Authors:  S A Narod; J Feunteun; H T Lynch; P Watson; T Conway; J Lynch; G M Lenoir
Journal:  Lancet       Date:  1991-07-13       Impact factor: 79.321

3.  Genetic epidemiology of breast cancer: segregation analysis of 200 Danish pedigrees.

Authors:  W R Williams; D E Anderson
Journal:  Genet Epidemiol       Date:  1984       Impact factor: 2.135

4.  The blood groups of Icelanders.

Authors:  O Bjarnason; V Bjarnason; J H Edwards; S Fridriksson; M Magnusson; A E Mourant; D Tills
Journal:  Ann Hum Genet       Date:  1973-04       Impact factor: 1.670

5.  Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer.

Authors:  A Arason; R B Barkardóttir; V Egilsson
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

6.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors:  D F Easton; D T Bishop; D Ford; G P Crockford
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

7.  Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer.

Authors:  H Tulinius; V Egilsson; G H Olafsdóttir; H Sigvaldason
Journal:  BMJ       Date:  1992-10-10

8.  Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship.

Authors:  J M Schildkraut; N Risch; W D Thompson
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

9.  Genetic analysis of breast cancer in the cancer and steroid hormone study.

Authors:  E B Claus; N Risch; W D Thompson
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

10.  Cancer mortality in the first degree relatives of young breast cancer patients.

Authors:  K E Anderson; D F Easton; F E Matthews; J Peto
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

View more
  20 in total

1.  Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?

Authors:  O M Serova; S Mazoyer; N Puget; V Dubois; P Tonin; Y Y Shugart; D Goldgar; S A Narod; H T Lynch; G M Lenoir
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

2.  A low proportion of BRCA2 mutations in Finnish breast cancer families.

Authors:  P Vehmanen; L S Friedman; H Eerola; L Sarantaus; S Pyrhönen; B A Ponder; T Muhonen; H Nevanlinna
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

3.  Population genetics of BRCA1 and BRCA2.

Authors:  C I Szabo; M C King
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

4.  The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment.

Authors:  P L Chen; C F Chen; Y Chen; J Xiao; Z D Sharp; W H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

5.  Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.

Authors:  S Håkansson; O Johannsson; U Johansson; G Sellberg; N Loman; A M Gerdes; E Holmberg; N Dahl; N Pandis; U Kristoffersson; H Olsson; A Borg
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

Review 6.  The role of the BRCA2 gene in susceptibility to prostate cancer revisited.

Authors:  Elaine A Ostrander; Miriam S Udler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

Review 7.  Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.

Authors:  Dawn C Allain
Journal:  J Mol Diagn       Date:  2008-08-07       Impact factor: 5.568

8.  CDKN2A mutations and melanoma risk in the Icelandic population.

Authors:  A M Goldstein; S N Stacey; J H Olafsson; G F Jonsson; A Helgason; P Sulem; B Sigurgeirsson; K R Benediktsdottir; K Thorisdottir; R Ragnarsson; J Kjartansson; J Kostic; G Masson; K Kristjansson; J R Gulcher; A Kong; U Thorsteinsdottir; T Rafnar; M A Tucker; K Stefansson
Journal:  J Med Genet       Date:  2008-01-04       Impact factor: 6.318

9.  A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland.

Authors:  A Arason; A Jonasdottir; R B Barkardottir; J T Bergthorsson; M D Teare; D F Easton; V Egilsson
Journal:  J Med Genet       Date:  1998-06       Impact factor: 6.318

10.  The effect of a single BRCA2 mutation on cancer in Iceland.

Authors:  H Tulinius; G H Olafsdottir; H Sigvaldason; A Arason; R B Barkardottir; V Egilsson; H M Ogmundsdottir; L Tryggvadottir; S Gudlaugsdottir; J E Eyfjord
Journal:  J Med Genet       Date:  2002-07       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.